tiprankstipranks
Rakovina Therapeutics Inc (TSE:RKV)
TSXV:RKV
Canadian Market

Rakovina Therapeutics Inc (RKV) Financial Statements

1 Followers

Rakovina Therapeutics Inc Financial Overview

Rakovina Therapeutics Inc's market cap is currently ―. The company's EPS TTM is C$-0.037; its P/E ratio is -2.41; Rakovina Therapeutics Inc is scheduled to report earnings on May 23, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -582.86KC$ -579.21KC$ -641.79KC$ -647.18KC$ -726.60K
EBITDAC$ -447.73KC$ -445.55KC$ -509.60KC$ -512.05K-
Net Income Common StockholdersC$ -646.97KC$ -601.40KC$ -641.79KC$ -647.18KC$ -716.13K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 813.33KC$ 1.21MC$ 607.60KC$ 896.83KC$ 1.35M
Total AssetsC$ 5.82MC$ 6.39MC$ 5.58MC$ 6.12MC$ 6.87M
Total DebtC$ 1.31MC$ 1.30MC$ 0.00C$ 0.00C$ 0.00
Net DebtC$ 500.55KC$ 86.86KC$ -607.60KC$ -896.83KC$ -1.35M
Total LiabilitiesC$ 1.50MC$ 1.44MC$ 168.95KC$ 107.05KC$ 6.87M
Stockholders EquityC$ 4.33MC$ 4.95MC$ 5.41MC$ 6.01MC$ 6.62M
Cash Flow-
Free Cash FlowC$ -395.37KC$ -800.10KC$ -289.23KC$ -449.93KC$ -1.47M
Operating Cash FlowC$ -395.37KC$ -800.10KC$ -289.23KC$ -449.93KC$ -1.47M
Investing Cash Flow-----
Financing Cash Flow-C$ 1.40M--C$ 2.15K
Currency in CAD

Rakovina Therapeutics Inc Earnings and Revenue History

Rakovina Therapeutics Inc Debt to Assets

Rakovina Therapeutics Inc Cash Flow

Rakovina Therapeutics Inc Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis